These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34090807)

  • 1. Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST and CA19-9/γ-GGT for jaundiced PDAC patients).
    Huang X; Lu Z; Zhang K; Wang G; Cai B; Wu P; Yin J; Miao Y; Jiang K
    Pancreatology; 2021 May; ():. PubMed ID: 34090807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
    Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
    Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma.
    Ermiah E; Eddfair M; Abdulrahman O; Elfagieh M; Jebriel A; Al-Sharif M; Assidi M; Buhmeida A
    Mol Clin Oncol; 2022 Aug; 17(2):126. PubMed ID: 35832472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Concurrent Cholestasis Alter the Prognostic Value of Preoperatively Elevated CA19-9 Serum Levels in Patients with Pancreatic Head Adenocarcinoma?
    Anger F; Lock JF; Klein I; Hartlapp I; Wiegering A; Germer CT; Kunzmann V; Löb S
    Ann Surg Oncol; 2022 Dec; 29(13):8523-8533. PubMed ID: 36094690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study.
    Dong Q; Yang XH; Zhang Y; Jing W; Zheng LQ; Liu YP; Qu XJ
    World J Surg Oncol; 2014 Jun; 12():171. PubMed ID: 24890327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.
    Chen J; Zhao T; Jia S; Zhou S; Zhou L; Wang S; Ding G; Jiang G; Cao L
    J Cancer; 2018; 9(4):650-659. PubMed ID: 29556322
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum CA125 levels predict the prognosis in hyperbilirubinemia patients with resectable pancreatic ductal adenocarcinoma.
    Chen T; Zhang MG; Xu HX; Wang WQ; Liu L; Yu XJ
    Medicine (Baltimore); 2015 May; 94(19):e751. PubMed ID: 25984661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma.
    Gu X; Zhou R; Li C; Liu R; Zhao Z; Gao Y; Xu Y
    BMC Cancer; 2019 May; 19(1):456. PubMed ID: 31092213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year native liver survival analysis in biliary atresia from a single large Chinese center: The death/liver transplantation hazard change and the importance of rapid early clearance of jaundice.
    Wang Z; Chen Y; Peng C; Pang W; Zhang T; Wu D; Shen Q; Li M
    J Pediatr Surg; 2019 Aug; 54(8):1680-1685. PubMed ID: 30518490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma.
    Gong Y; Song L; Ou L; Lu YY; Huang X; Zeng Q
    Iran J Med Sci; 2023 Jul; 48(4):401-413. PubMed ID: 37456201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
    Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center.
    Wu Z; Zhao P; Wang Z; Huang X; Wu C; Li M; Wang L; Tian B
    Front Oncol; 2022; 12():966256. PubMed ID: 35965560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer.
    Wu L; Huang P; Wang F; Li D; Xie E; Zhang Y; Pan S
    Ann Transl Med; 2015 Dec; 3(21):328. PubMed ID: 26734638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant.
    Liu W; Liu Q; Wang W; Wang P; Chen J; Hong T; Zhang N; Li B; Qu Q; He X
    J Cancer; 2018; 9(10):1804-1812. PubMed ID: 29805707
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative carbohydrate antigen 19-9 and standard uptake value of positron emission tomography-computed tomography as prognostic markers in patients with pancreatic ductal adenocarcinoma.
    Moon D; Kim H; Han Y; Byun Y; Choi Y; Kang J; Kwon W; Jang JY
    J Hepatobiliary Pancreat Sci; 2022 Oct; 29(10):1133-1141. PubMed ID: 33063453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum CA19-9 predicts postoperative pancreatic fistula in PDAC patients: retrospective analysis at a single institution.
    Sugita H; Okabe H; Ogawa D; Hirao H; Kuroda D; Taki K; Tomiyasu S; Hirota M
    BMC Surg; 2022 Oct; 22(1):367. PubMed ID: 36307795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Prognostic Biomarker in Patients with Pancreatic Head Carcinoma.
    Lyu SC; Wang J; Huang M; Wang HX; Zhou L; He Q; Lang R
    Cancer Manag Res; 2021; 13():4887-4898. PubMed ID: 34188542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study.
    Itoh S; Tsujita E; Fukuzawa K; Sugimachi K; Iguchi T; Ninomiya M; Maeda T; Kajiyama K; Adachi E; Uchiyama H; Utsunomiya T; Ikeda Y; Maekawa S; Toshima T; Harada N; Yoshizumi T; Mori M
    Pancreatology; 2021 Oct; 21(7):1356-1363. PubMed ID: 34426076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis.
    van Manen L; Groen JV; Putter H; Vahrmeijer AL; Swijnenburg RJ; Bonsing BA; Mieog JSD
    Biomarkers; 2020 Mar; 25(2):186-193. PubMed ID: 32009482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.